SSRIs reduce cardiac risk, increase bleeding in ACS patients

By  

Reactions Weekly, Vol. 1, Iss. 1159, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Rivaroxaban demonstrates non-inferiority, halves major bleeding risk

By  

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Major bleeding: management and risk reduction in acute coronary syndromes

By Cavender Matthew A   Rao Sunil V   Ohman E Magnus  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 11, 2008-08 ,pp. : 1869-1883

Informa Healthcare

Access to resources Recommend Favorite

Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study

By Tsu Laura V.   Berry Andrew   Wald Erin   Ehrlich Cassandra  

The Consultant Pharmacist, Vol. 30, Iss. 7, 2015-07 ,pp. : 395-402

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Intensive statin therapy reduces HF risk in ACS

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite